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Background: Malaria is among the most prevalent parasitic diseases worldwide. In Brazil, malaria is concentrated in
the northern region, where Plasmodium vivax accounts for 85% disease incidence. The role of genetic factors in
host immune system conferring resistance/susceptibility against P. vivax infections is still poorly understood.
Methods: The present study investigates the influence of polymorphisms in 18 genes related to the immune
system in patients with malaria caused by P. vivax. A total of 263 healthy individuals (control group) and 216
individuals infected by P. vivax (malaria group) were genotyped for 33 single nucleotide polymorphisms (SNPs) in
IL1B, IL2, IL4, IL4R, IL6, IL8, IL10, IL12A, IL12B, IL12RB1, SP110, TNF, TNFRSF1A, IFNG, IFNGR1, VDR, PTPN22 and P2X7 genes.
All subjects were genotyped with 48 ancestry informative insertion-deletion polymorphisms to determine the
proportion of African, European and Amerindian ancestry. Only 13 SNPs in 10 genes with differences lower than
20% between cases and controls in a Poisson Regression model with age as covariate were further investigated
with a structured population association test.
Results: The IL1B gene -5839C > T and IL4R 1902A > G polymorphisms and IL12RB1 -1094A/-641C and TNF -1031
T/-863A/-857 T/-308 G/-238 G haplotypes were associated with malaria susceptibility after population structure
correction (p = 0.04, p = 0.02, p = 0.01 and p = 0.01, respectively).
Conclusion: Plasmodium vivax malaria pathophysiology is still poorly understood. The present findings reinforce
and increase our understanding about the role of the immune system in malaria susceptibility.
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Malaria remains one of the most important parasitic
infections in the world with almost 250 million new
cases diagnosed annually [1]. It is caused by infection
with one or more of five species of Plasmodium para-
sites. Plasmodium vivax is the second most common
cause of malaria in the world after Plasmodium falcip-
arum, with high incidence in Asia, Central and South
America causing high morbidity to these populations [2-5].
Traditionally, Brazil has been responsible for almost
half of all cases of malaria in Latin America. In 2010,* Correspondence: mara.hutz@ufrgs.br
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reproduction in any medium, provided the or334,618 cases of malaria (283,384 caused by P. vivax) were
reported in this country [1,6].
Plasmodium vivax has unique biological features that
distinguish it as a species. The most obvious features
that distinguish P. vivax from P. falciparum include the
development of dormant forms (hypnozoites) in the liver
that cause subsequent infections in the blood called
relapses, which add a substantial number of cases to the
general burden of the disease and present one of the
most challenging bottlenecks for vivax malaria eradica-
tion [7].
A sensitive balance between pro- and anti-inflammatory
immune response, primarily mediated by cytokines
released by T helper (Th) cells and macrophages, is neces-
sary for an adequate response to malaria. An early pro-Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and macrophages helps to reduce parasitaemia; how-
ever, a second anti-inflammatory response mediated by
a set of Th2 cells and monocytes is required to control
malaria by preventing organ damage and more severe
symptoms. Timing and intensity between Th1 and Th2
response and auto-regulation can influence both path-
ology of infection and its progress [8-10]. Influence of
the immune system gene polymorphisms with resist-
ance/susceptibility and severity in P. falciparum malaria
in Africa and Asia have been reported [11], however the
influence of these polymorphisms in P. vivax infection
is still poorly investigated. In patients with P. vivax mal-
aria from India, two single nucleotide polymorphisms
(SNP) in the TNF promoter (−308 G > A and -1031C > T)
were associated with tumour necrosis factor (TNF) levels
and clinical symptoms but not with susceptibility [12]. A
recent work, demonstrated an association of +874A > T in
IFNG gene with Interferon gamma (IFN-γ) plasma levels
but not with -1082 T > C in IL10 gene with interleukin
(IL) 10 plasma levels in patients infected by P. vivax from
Brazil [13].
Brazil has a peculiar epidemiological situation, as one
of the few countries around the world with P. vivax pre-
dominance [6]. Data on susceptibility to P. vivax infec-
tion allied to several particularities of the Brazilian
Amazonian region, including the diverse genetic back-
ground of its population, indicate that the generalization
of findings from Southeast Asia may not be appropriate
for this region [6]. The present work aims to investigate
the influence of 33 SNPs in genes related to the immune
system and susceptibility to P. vivax malaria in an Ama-
zonian population.Methods
Study population
A total of 216 patients were diagnosed with P. vivax
malaria at the Evandro Chagas Institute, Belém, Pará be-
tween 2002–2009. All patients were diagnosed by thick
blood smear as recommended by the Brazilian Ministry
of Health [14]. The patients received the standard treat-
ment 1,500 mg of chloroquine associated with 210 mg
of primaquine in seven days. Between 2006 and 2008,
263 healthy controls were recruited at the Federal Uni-
versity of Pará. Unrelated subjects were interviewed at
the Human and Medical Genetics Laboratory and agreed
to donate DNA samples to compose a population sam-
ple for genetic studies. The individuals enrolled in the
study were born in Pará state in the Brazilian Amazon-
ian region. Patients and controls provided their written
informed consent to participate in this study. The Ethics
Committees of the Evandro Chagas Institute and Federal
University of Pará approved the study protocol.Genotyping
Genomic DNA was extracted from peripheral blood
leukocyte subjects using proteinase K digestion and stand-
ard phenol-chloroform procedures [15]. All subjects were
genotyped for a set of 48 bi-allelic short insertion/deletion
(indels) polymorphisms, validated as ancestry informative
markers. The genotyping procedure was performed by
three multiplex reactions as described elsewhere [16].
The 33 immune system gene SNPs were determined by
allelic discrimination with Taqman 5’-nuclease assays. A
total of 30 polymorphisms were genotyped with validated
genotyping assays (Real Time PCR, Applied Biosystems,
CA, USA). Three variants -174C >G (rs1800795), -863A
> C (rs180030) and 874A > T (rs2430561) were genotyped
by custom genotyping assay by design (Applied Biosys-
tems, CA, USA). All assays were genotyped according to
the manufacturer’s recommended protocol.
Statistical analyses
Allele and genotype frequencies were estimated by gene
counting. Deviation from Hardy-Weinberg equilibrium
was assessed by Qui-square tests with Bonferroni correc-
tion. Haplotype frequencies and linkage disequilibrium
were estimated with PHASE 2.1.1 [17]. Differences be-
tween malaria and control samples on age and ancestry
were estimated by Mann–Whitney tests. The individual
proportions of European, African and Amerindian gen-
etic ancestry were estimated using the STRUCTURE
software 2.3.3 assuming three parental populations (Eur-
opeans, Africans and Amerindians), and running with
200,000 burn-in period and 200,000 Markov Chain
Monte Carlo repetitions after burning [18]. Poisson
regressions were performed to assess the association be-
tween polymorphisms or haplotypes and age. The asso-
ciation between malaria cases and controls was
performed using the STRAT software with 10,000 simu-
lations [19]. STRAT utilizes the STRUCTURE output to
test for association in the presence of population stratifi-
cation based on individual ancestry information. Mann–
Whitney, Qui-square and Poisson Regression tests were
performed using the SPSS18.0 statistical package for
WindowsW. Statistical significance was defined as a two-
tailed P-value < 0.05.
Results
The 33 SNPs investigated, their location in the gene and
the allele frequencies observed in malaria cases and con-
trols are shown in Additional file 1. The genotype distri-
bution did not deviate significantly from Hardy-Weinberg
equilibrium in both samples (Additional file 2).
Age and mean ancestry proportions of the subjects en-
rolled in the study are shown in Table 1. The control
group was younger (32.8 ± 16.5 years) and presented a
larger proportion of European ancestry (0.436 ± 0.13)
Table 1 Age and genetic ancestry of malaria and control
subjects
Characteristics Controls Malaria P valuea
N 263 216
Age (y) 32.8 ± 16.5 35.4 ± 15.3 0.003
Genetic Ancestry
African 0.245 ± 0.10 0.246 ± 0.09 0.6
European 0.436 ± 0.13 0.412 ± 0.11 0.03
Native American 0.319 ± 0.11 0.342 ± 0.12 0.06
Values for age and genetic ancestry are expressed as mean ± SD.
a Mann–Whitney test p values.
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respectively). These differences were statistically signifi-
cant between groups (p = 0.003 and p = 0.037, respect-
ively). Due to this significant difference in age, a Poisson
regression analysis using age as a covariate was per-
formed. Only the polymorphisms with P <0.20 between
malaria and control samples were chosen for further
analyses (Additional file 3).
Because ancestry proportions differ between malaria
patients and controls (Table 1), the association between
13 SNPs, chosen from the Poisson regression analyses,
was performed using the STRAT software (Table 2).
After population structure correction, only IL1B -5839C
> T and IL4R 1902A > G polymorphisms were associated
with malaria susceptibility. The IL1B -5839C and IL4R
1902A alleles are 8.2% and 6.2% respectively more fre-
quent in malaria patients than in controls. Haplotype as-
sociation tests adjusted for population stratification by
the STRAT software are shown in Table 3. IL12RB1 and
TNF haplotypes were associated with malaria suscepti-
bility. The IL12RB1AC (−1094/-641) haplotype is only
present in the malaria sample whereas the TNF TATGGTable 2 Structured population association test between mala
Gene SNP dbSNP ID Allele
IL1B −5839C > T rs1143629 C
IL4R 1902A > G rs1801275 A
IL6 −174C > G rs1800795 C
IL10 −592A > C rs1800872 A
IL12B 458A > G rs2546890 A
IL12RB1 −1094A > G rs375947 G
−641C > T rs11575934 G
SP110 14622C > T rs2114592 T
TNF −1031C > T rs1799964 C
−238A > G rs361525 A
−857C > T rs1799724 T
IFNG 874A > T rs2430561 A
IFNGR1 −56 T > C rs2234711 C(−1031/-863/-857/-308/-238) haplotype is 2.5% more
frequent in individuals with malaria.
Discussion
In a gene-based association study with 18 candidate
genes for malaria susceptibility using 33 SNPs as genetic
markers, this study demonstrated that IL1B, IL4R,
IL12RB1 and TNF genes were associated with suscepti-
bility to P. vivax malaria in a population of Pará state,
Brazil.
Cytokines are immunomodulatory proteins produced
by a wide variety of cells, and with very complex activ-
ities. A functional cytokine network is a central element
in the homeostasis of the immune response and its alter-
ation may lead to an abnormal immune response.
Hence, recent interest has focused upon genes regulating
the cytokine expression; in particular on gene poly-
morphisms that may influence the levels of expression
and therefore the overall immune response. Despite evi-
dence demonstrating the importance of IL1B, IL4R,
IL12RB1 and TNF genes in P. falciparum malaria path-
ology, the influence of these variants in P. vivax infec-
tions is unknown.
Independent studies reported differences in immune
system gene polymorphisms frequencies in distinct
malaria-endemic regions [20]. The relevance of these
polymorphisms in malaria infections could differ be-
tween distinct genetic background populations or etio-
logic agents, highlighting the importance of studies in
different endemic regions. Due to the high admixed na-
ture of the Brazilian population and its substructuring
consequences in genetic association studies, this study
dealt with this issue with extreme care. The population
from Pará state has European, African and Amerindian




46.2 54.4 0.01 0.04
32.5 38.7 0.04 0.02
20.9 17.8 0.25 0.50
34.2 37.7 0.27 0.40
40.1 33.6 0.04 0.12
23.4 20.9 0.36 0.19
20.8 19.9 0.72 0.79
8.2 9.3 0.55 0.75
24.0 21.9 0.44 0.10
7.4 6.1 0.44 0.37
14.4 15.0 0.79 0.12
25.8 28.3 0.38 0.29
39.8 38.1 0.59 0.71
Table 3 Structured population association test for
haplotypes association between malaria and control
samples
Gene Haplotype Allele Frequency (%) PQui
2 PStrat
Control Malaria
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employed to provide reliable results for this specific
population.
The IL-1β, IL-12 and the TNF together with IFN-γ are
the major cytokines in pro-inflammatory Th1 immune
response. IL-1β is predominantly secreted by monocytes
and macrophages in initial immune response against
infections [22-24] and helps to modulate the expression
of IFN-γ and promote the polarization to Th17 immune
response in certain circumstances [25,26]. IL-12 pro-
motes IFN-γ production by T and natural killer (NK)
cells and exerts its biological function through binding
to the heteromeric interleukin 12 receptor (IL-12R) β1
and β2. The deficiency in IL-12R expression interferes in
IL-12 functions and is associated with severe infection in
humans [27,28]. TNF is produced by monocytes and
macrophages and its role in malaria pathology was
investigated due to reports of high levels of this cytokine
in cerebral malaria patients [29].
IL1B gene was associated with P. falciparum malaria
in African populations only [30,31]. The present study is
the first to report the association of -5839C > T SNP
promoter with P. vivax malaria susceptibility. The
-5839C allele presented a higher frequency in malaria
patients then in controls. Despite that, the function of
this intronic SNP is not completely elucidated, variability
of this important pro-inflammatory gene could represent
an important factor in immune regulation. The associ-
ation of haplotype -31C/-511A in IL1B gene promoter
with severe malarial anaemia and circulating IL-1β low
levels in children with P. falciparum malaria from Kenya
have been shown recently [32], however, the IL1B -31C
> T polymorphism was not associated with cerebral mal-
aria in Thailand [33]. In the present study these two
SNPs were not associated with vivax malaria, demon-
strating a possible difference in the contribution of these
polymorphisms to malaria pathology among populations
and parasites. Complementary studies in IL1B gene and
IL-1β levels are important to help understand how this
gene influences malaria susceptibility and severity.
Recent work in Kenyan patients infected with P. falcip-
arum demonstrated that IL12RB1 rs4229774 and
rs383483 polymorphisms were associated with protec-
tion against severe malarial anaemia and high parasit-
aemia levels, but not susceptibility [34]. The present
study reports the association of IL12RB1 -1094A/-641C
haplotype with P. vivax malaria susceptibility. Despite
the lower frequency in the study subjects, this haplotype
is present only in the individuals with malaria, suggest-
ing a possible influence in malaria response. The -641C
allele leads to a missense variant (i.e. encodes a different
amino acid) and can modify the receptor properties and
interfere with IL-12 ligation and function. These results
suggest that IL12RB1 variants are important in malaria
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sary to better understand the IL12RB1 influence on sus-
ceptibility and severity in P. vivax malaria.
Polymorphisms in TNF gene promoter have been
reported to be associated with symptoms and severity of
P. falciparum malaria in different African and Asian
populations [35-39]. The present work demonstrated
that the TATGG (−1031/-863/-857/-308/-238) TNF
haplotype is associated with P. vivax malaria in a Brazil-
ian population. TNF is an important pro-inflammatory
cytokine and the TATGG haplotype diverge in two
alleles (−1031C and -308A) associated with TNF levels
in vivax malaria infection in India [12]. In that work it
was hypothesized that -1031C and -308A alleles are rare
in Indian malaria patients due to a possible protective
effect. The presence of -1031 T and -308 G alleles in
TATGG haplotype could be an important factor in vivax
malaria susceptibility.
Interleukin 4 receptor (IL-4R), together with IL-4 and
IL-13 are important Th2 anti-inflammatory immune re-
sponse modulators. IL-4R is the principal receptor of
these interleukins, and when it is blocked IL-4 and IL-13
function is aborted preventing Th2 immune response
modulation [40]. Only a few works investigated IL-4R
variants influence on malaria infections. In the present
investigation an association of 1902A > G SNP with mal-
aria susceptibility was observed. The 1902 G allele create
a missense variant and potentially can modify the recep-
tor properties and interfere with IL-4 and IL-13 func-
tions. It has been shown that the immune response via
IL-4, IL4R and IL-13 pathway is important to prevent
malaria infection in mice [41,42]. These studies demon-
strated that knockout mice for IL4 and IL4R genes have
high resistance to malaria liver stage caused by sporo-
zoites. The absence of modulation mediated by IL-4 to
Th2 immune response, the Th1 response mediated by
IFN-γ is maintained and promotes a rapid cellular re-
sponse against sporozoites. The present study shows that
1902A allele is more frequent in malaria patients, al-
though 1902 G presents a higher overall frequency in
the study population, 1902A allele could influence the
co-regulation between Th1 and Th2 immune response
against malaria infections. New complementary studies
will be necessary to elucidate the IL4R gene importance
in vivax malaria infection.
IL4, IL10, IL12B, IFNG and IFNGR1 genes polymorph-
isms were associated with symptoms and severity of P.
falciparum malaria in studies from African and Asian
populations [11]. In the present study, polymorphisms in
these genes were not associated with susceptibility to
malaria caused by P. vivax. Differences in malaria patho-
physiology caused by these two species of parasites could
be a possible explanation for the divergences reported.
Plasmodium falciparum malaria presents a more acuteform of infection reaching more than 50% of erythro-
cytes leading to cyto-adherence, organ damaged, severe
malarial anaemia and cerebral malaria. Malaria caused
by P. vivax is characterized by a long incubation period
and milder initial symptoms. The parasite infects ap-
proximately 2 to 5% of erythrocytes, and can remain
dormant in the liver as hypnozoites leading to subse-
quently relapses [43]. Studies have linked high levels of
pro-inflammatory cytokines, such as TNF, IL-1β, IL-6
and IFN-γ in P. falciparum infections [44-47] and TNF,
IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10 e IL-12 cytokines with
P. vivax infections [13,48-50]. These differences in cyto-
kine profile and gene polymorphisms should reflect a
distinct dynamic between the regulatory pathway of pro-
and anti-inflammatory cytokines in P. falciparum and P.
vivax malaria response, pathology and outcome.
Conclusions
Knowledge of the relationships between genetics, sus-
ceptibility to and severity of malaria infections is essen-
tial to identify subjects at higher risk and to develop
specific preventive measures. This study showed that
genetic polymorphisms of some interleukins involved in
the immune response to P. vivax infection influence sus-
ceptibility to malaria. The present findings reinforce and
increase our understanding about the role of the im-
mune system in malaria susceptibility. However, to ex-
pand knowledge about the actions of the immune
system in the pathophysiology of vivax malaria it is ne-
cessary to conduct population-based longitudinal
studies.
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